taladegib
AssetAlso ENV-101, LY-2940680
Inhibitor of the Hedgehog signaling pathway.
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- SMO
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Idiopathic pulmonary fibrosis
Phase 2, businesswire.com, 8 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets1
- Competitors12
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.